[Federal Register Volume 61, Number 95 (Wednesday, May 15, 1996)]
[Notices]
[Page 24515]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-12122]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on March 27, 1996, Research
Biochemicals, Limited Partnership, Attn: Richard Milius, One Strathmore
Road, Natick, Massachusetts 01760, made application to the Drug
Enforcement Administration (DEA) for registration as a bulk
manufacturer of the basic classes of controlled substances listed
below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................................... I
Methcathinone (1237)....................................... I
Alpha-Ethyltryptamine (7249)............................... I
Lysergic acid diethylamide (7315).......................... I
4-Bromo-2,5-dimethoxyamphetamine (7391).................... I
2,5-Dimethoxyamphetamine (7396)............................ I
3,4-Methylenedioxymeth- amphetamine (7405)................. I
Dimethyltryptamine (7435).................................. I
1-[1-(2-Thienyl) cyclohexyl] piperidine (7470)............. I
Heroin (9200).............................................. I
Normorphine (9313)......................................... I
Phencyclidine (7471)....................................... II
Benzoylecgonine (9180)..................................... II
------------------------------------------------------------------------
The firm plans to manufacture the listed controlled substances for
laboratory reference standards and neurochemicals.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the above application.
Any such comments or objections may be addressed, in quintuplicate,
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, United States Department of Justice,
Washington, DC 20537, Attention: DEA Federal Register Representative
(CCR), and must be filed no later than July 15, 1996.
Dated: May 6, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 96-12122 Filed 5-14-96; 8:45 am]
BILLING CODE 4410-09-M
